MGC Venture Partners 2013 GP, LLC 4

Accession 0001140361-19-013900

CIK 0001447362other

View on SEC.gov Company Profile

Filed

Jul 30, 8:00 PM ET

Accepted

Jul 31, 5:57 PM ET

Size

37.3 KB

Accession

0001140361-19-013900

Insider Transaction Report

Form 4

Period: 2019-07-29

CASTLE BIOSCIENCES INCCSTL

MGC Venture Partners 2013 GP, LLC

10% Owner

Transactions

Purchase
Common Stock
2019-07-29$16.00/sh+62,500$1,000,000→ 1,496,855 total(indirect: See footnotes)
Purchase
Common Stock
2019-07-29$16.00/sh+115,300$1,844,800→ 115,300 total(indirect: See footnotes)
Conversion
Common Stock
2019-07-29$12.80/sh+97,428$1,247,078→ 1,434,355 total(indirect: See footnotes)
Conversion
Series E-1 Preferred Stock
2019-07-29−463,453→ 0 total(indirect: See footnotes)
→ CommonStock (380,190 underlying)
Conversion
Series E-2 Preferred Stock
2019-07-29−158,379→ 0 total(indirect: See footnotes)
→ CommonStock (129,925 underlying)
Conversion
Common Stock
2019-07-29+1,336,927→ 1,336,927 total(indirect: See footnotes)
Purchase
Common Stock
2019-07-29$16.00/sh+134,700$2,155,200→ 134,700 total(indirect: See footnotes)
Conversion
Series A Preferred Stock
2019-07-29−19,524→ 0 total(indirect: See footnotes)
→ CommonStock (16,015 underlying)
Conversion
Series E-3 Preferred Stock
2019-07-29−142,843→ 0 total(indirect: See footnotes)
→ CommonStock (117,180 underlying)
Conversion
Convertible Promissory Note
2019-07-29−1,200,000→ 0 total(indirect: See footnotes)
Exercise: $12.80→ Common Stock (97,428 underlying)
Conversion
Series D Preferred Stock
2019-07-29−337,754→ 0 total(indirect: See footnotes)
→ CommonStock (277,074 underlying)
Conversion
Series F Preferred Stock
2019-07-29−507,762→ 0 total(indirect: See footnotes)
→ CommonStock (416,537 underlying)

MGC Venture Partners 2013, L.P.

10% Owner

Transactions

Conversion
Series E-2 Preferred Stock
2019-07-29−158,379→ 0 total(indirect: See footnotes)
→ CommonStock (129,925 underlying)
Conversion
Series F Preferred Stock
2019-07-29−507,762→ 0 total(indirect: See footnotes)
→ CommonStock (416,537 underlying)
Conversion
Convertible Promissory Note
2019-07-29−1,200,000→ 0 total(indirect: See footnotes)
Exercise: $12.80→ Common Stock (97,428 underlying)
Conversion
Common Stock
2019-07-29+1,336,927→ 1,336,927 total(indirect: See footnotes)
Conversion
Series E-1 Preferred Stock
2019-07-29−463,453→ 0 total(indirect: See footnotes)
→ CommonStock (380,190 underlying)
Conversion
Common Stock
2019-07-29$12.80/sh+97,428$1,247,078→ 1,434,355 total(indirect: See footnotes)
Purchase
Common Stock
2019-07-29$16.00/sh+62,500$1,000,000→ 1,496,855 total(indirect: See footnotes)
Purchase
Common Stock
2019-07-29$16.00/sh+115,300$1,844,800→ 115,300 total(indirect: See footnotes)
Purchase
Common Stock
2019-07-29$16.00/sh+134,700$2,155,200→ 134,700 total(indirect: See footnotes)
Conversion
Series A Preferred Stock
2019-07-29−19,524→ 0 total(indirect: See footnotes)
→ CommonStock (16,015 underlying)
Conversion
Series E-3 Preferred Stock
2019-07-29−142,843→ 0 total(indirect: See footnotes)
→ CommonStock (117,180 underlying)
Conversion
Series D Preferred Stock
2019-07-29−337,754→ 0 total(indirect: See footnotes)
→ CommonStock (277,074 underlying)

MGC Venture Partners 2018 GP, LLC

10% Owner

Transactions

Conversion
Common Stock
2019-07-29+1,336,927→ 1,336,927 total(indirect: See footnotes)
Conversion
Common Stock
2019-07-29$12.80/sh+97,428$1,247,078→ 1,434,355 total(indirect: See footnotes)
Purchase
Common Stock
2019-07-29$16.00/sh+62,500$1,000,000→ 1,496,855 total(indirect: See footnotes)
Purchase
Common Stock
2019-07-29$16.00/sh+115,300$1,844,800→ 115,300 total(indirect: See footnotes)
Purchase
Common Stock
2019-07-29$16.00/sh+134,700$2,155,200→ 134,700 total(indirect: See footnotes)
Conversion
Series F Preferred Stock
2019-07-29−507,762→ 0 total(indirect: See footnotes)
→ CommonStock (416,537 underlying)
Conversion
Series A Preferred Stock
2019-07-29−19,524→ 0 total(indirect: See footnotes)
→ CommonStock (16,015 underlying)
Conversion
Series E-1 Preferred Stock
2019-07-29−463,453→ 0 total(indirect: See footnotes)
→ CommonStock (380,190 underlying)
Conversion
Convertible Promissory Note
2019-07-29−1,200,000→ 0 total(indirect: See footnotes)
Exercise: $12.80→ Common Stock (97,428 underlying)
Conversion
Series D Preferred Stock
2019-07-29−337,754→ 0 total(indirect: See footnotes)
→ CommonStock (277,074 underlying)
Conversion
Series E-2 Preferred Stock
2019-07-29−158,379→ 0 total(indirect: See footnotes)
→ CommonStock (129,925 underlying)
Conversion
Series E-3 Preferred Stock
2019-07-29−142,843→ 0 total(indirect: See footnotes)
→ CommonStock (117,180 underlying)

MGC VENTURE PARTNERS 2018, L.P.

10% Owner

Transactions

Purchase
Common Stock
2019-07-29$16.00/sh+62,500$1,000,000→ 1,496,855 total(indirect: See footnotes)
Purchase
Common Stock
2019-07-29$16.00/sh+115,300$1,844,800→ 115,300 total(indirect: See footnotes)
Purchase
Common Stock
2019-07-29$16.00/sh+134,700$2,155,200→ 134,700 total(indirect: See footnotes)
Conversion
Series A Preferred Stock
2019-07-29−19,524→ 0 total(indirect: See footnotes)
→ CommonStock (16,015 underlying)
Conversion
Series D Preferred Stock
2019-07-29−337,754→ 0 total(indirect: See footnotes)
→ CommonStock (277,074 underlying)
Conversion
Series E-1 Preferred Stock
2019-07-29−463,453→ 0 total(indirect: See footnotes)
→ CommonStock (380,190 underlying)
Conversion
Series E-2 Preferred Stock
2019-07-29−158,379→ 0 total(indirect: See footnotes)
→ CommonStock (129,925 underlying)
Conversion
Common Stock
2019-07-29+1,336,927→ 1,336,927 total(indirect: See footnotes)
Conversion
Common Stock
2019-07-29$12.80/sh+97,428$1,247,078→ 1,434,355 total(indirect: See footnotes)
Conversion
Series E-3 Preferred Stock
2019-07-29−142,843→ 0 total(indirect: See footnotes)
→ CommonStock (117,180 underlying)
Conversion
Series F Preferred Stock
2019-07-29−507,762→ 0 total(indirect: See footnotes)
→ CommonStock (416,537 underlying)
Conversion
Convertible Promissory Note
2019-07-29−1,200,000→ 0 total(indirect: See footnotes)
Exercise: $12.80→ Common Stock (97,428 underlying)

MGC VENTURE PARTNERS QP 2018, L.P.

10% Owner

Transactions

Conversion
Common Stock
2019-07-29$12.80/sh+97,428$1,247,078→ 1,434,355 total(indirect: See footnotes)
Purchase
Common Stock
2019-07-29$16.00/sh+134,700$2,155,200→ 134,700 total(indirect: See footnotes)
Conversion
Series A Preferred Stock
2019-07-29−19,524→ 0 total(indirect: See footnotes)
→ CommonStock (16,015 underlying)
Conversion
Series D Preferred Stock
2019-07-29−337,754→ 0 total(indirect: See footnotes)
→ CommonStock (277,074 underlying)
Conversion
Series E-2 Preferred Stock
2019-07-29−158,379→ 0 total(indirect: See footnotes)
→ CommonStock (129,925 underlying)
Conversion
Convertible Promissory Note
2019-07-29−1,200,000→ 0 total(indirect: See footnotes)
Exercise: $12.80→ Common Stock (97,428 underlying)
Conversion
Common Stock
2019-07-29+1,336,927→ 1,336,927 total(indirect: See footnotes)
Purchase
Common Stock
2019-07-29$16.00/sh+62,500$1,000,000→ 1,496,855 total(indirect: See footnotes)
Conversion
Series E-1 Preferred Stock
2019-07-29−463,453→ 0 total(indirect: See footnotes)
→ CommonStock (380,190 underlying)
Purchase
Common Stock
2019-07-29$16.00/sh+115,300$1,844,800→ 115,300 total(indirect: See footnotes)
Conversion
Series E-3 Preferred Stock
2019-07-29−142,843→ 0 total(indirect: See footnotes)
→ CommonStock (117,180 underlying)
Conversion
Series F Preferred Stock
2019-07-29−507,762→ 0 total(indirect: See footnotes)
→ CommonStock (416,537 underlying)

Footnotes (9)

[F1]The shares of Common Stock issued upon conversion of the Preferred Stock were calculated by first aggregating all series of Preferred Stock held by MGC Venture Partners 2013, L.P. ("MGC 2013 LP"), in accordance with the terms of the then-effective Certificate of Incorporation of Castle Biosciences, Inc. (the "Issuer").
[F2]Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date.
[F3]Held directly by MGC 2013 LP.
[F4]MGC Venture Partners 2013 GP, LLC ("MGC 2013 GP") is the general partner of MGC 2013 LP. MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC Venture Partners 2018, L.P. ("MGC 2018 LP") and MGC Venture Partners QP 2018, L.P. ("MGC QP 2018 LP"). Each of MGC 2013 LP, MGC 2013 GP, MGC 2018 LP, MGC QP 2018 LP and MGC 2018 GP directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of some or all of the shares owned by MGC 2013 LP, MGC 2018 LP and MGC QP 2018 LP and, therefore, a "ten percent holder" hereunder.
[F5]Each of Joseph C. Cook, Jr., Joseph C. Cook III, Steven D. Singleton and Byron W. Smith are managing directors of MGC 2013 GP and share voting and investment power over the shares held by MGC 2013 LP. Each of Joseph C. Cook, Jr., Joseph C. Cook III, Steven D. Singleton, Byron W. Smith, Jay Ferguson and Rob Readnour are managing partners of MGC 2018 GP and share voting and investment power over the shares held by MGC 2018 LP and MGC QP 2018 LP. Each of the Reporting Persons disclaims beneficial ownership of the shares held by any other Reporting Persons reported herein, except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purposes.
[F6]The principal amount of the Convertible Promissory Note held by the designated Reporting Person was $1,200,000.00. Upon closing of the IPO, all unpaid principal and accrued interest outstanding on the Convertible Promissory Note (the "Conversion Amount") automatically converted into the number of shares of Common Stock equal to the Conversion Amount as of the date immediately prior to the closing date divided by 80% of the IPO price per share of $16.00 per share.
[F7]Represents a purchase from the underwriters in the Issuer's IPO.
[F8]Held directly by MGC 2018 LP.
[F9]Held directly by MGC QP 2018 LP.

Documents

1 file

4
form4.xmlPrimary
FORM 4

Issuer

CASTLE BIOSCIENCES INC

CIK 0001447362

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001783292

Filing Metadata

Form type: 4
Filed: Jul 30, 8:00 PM ET
Accepted: Jul 31, 5:57 PM ET
Size: 37.3 KB

View on SEC.gov